Advertisement
Advertisement
EKSO
Ekso Bionics Holdings, Inc. Common Stock
10.49
USDSponsored
+1.13
+12.05%
Feb 06, 16:00 UTC -5
Closed
After-Market
10.51
+0.02
+0.16%
EKSO Earnings Reports
Positive Surprise Ratio
EKSO beat 19 of 40 last estimates.
48%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Ekso Bionics Holdings, Inc. Common Stock earnings per share and revenue
On Oct 28, 2025, EKSO reported earnings of -0.54 USD per share (EPS) for Q3 25, beating the estimate of -1.16 USD, resulting in a 53.76% surprise. Revenue reached 4.23 million, compared to an expected 4.43 million, with a -4.65% difference. The market reacted with a +9.15% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
FAQ
What were Ekso Bionics Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ekso Bionics Holdings, Inc. Common Stock reported EPS of -$0.54, beating estimates by 53.76%, and revenue of $4.23M, -4.65% below expectations.
How did the market react to Ekso Bionics Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 9.15%, changed from $4.81 before the earnings release to $5.25 the day after.
When is Ekso Bionics Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Ekso Bionics Holdings, Inc. Common Stock's next earnings report?
Based on --
analysts, Ekso Bionics Holdings, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement